Category: Healthcare Finance News

Aetna drops Walgreens from its Illinois Medicaid plan

The removal of one pharmacy chain from the network has not created or contributed to network access issues, Aetna says.

Haven disbands, ending speculation on what innovation at such a scale could do

When formed in January 2018, the joint venture was expected to up-end the healthcare industry.

COVID-19 treatment is the first synthetic biological drug to receive FDA approval for Phase 3 trials

Carrimycin includes antiviral, anti-inflammatory and anti-fibrosis effects in addition to the antibacterial effect.

Cigna officially sells group life, accident, and disability insurance business to New York Life

The $6.3 billion acquisition is the largest in New York Life’s company history, according to chairman and CEO Ted Mathas.
The $6.3 billion acquisition is the largest in New York Life’s company history, according to chairman and CEO Ted Mathas.

CMS names an e-prescribing standard for prior authorization to expedite patient access to medications

The rule is intended to allow prescribers to see that a drug is subject to prior authorization while they are prescribing it.

Allergists offer reassurance regarding potential allergic reactions to COVID-19 vaccines

Patients with severe allergies to foods, oral drugs, latex or venom can still safely receive the COVID-19 vaccines.

Connecticut nursing homes to get $31.2 million in additional COVID-19 aid

The state’s nursing homes have seen more than 10,000 COVID-19 cases and close to 2,000 deaths.
The state’s nursing homes have seen more than 10,000 COVID-19 cases and close to 2,000 deaths.

Blood vessel damage, inflammation found in COVID-19 patients’ brains, but no infection

The findings give healthcare workers an insight into how patients may be affected, and could lead to more effective treatments.

Moderna vaccine shows 94.1% efficacy in a Phase 3 clinical trial

There were no safety issues found and the side effects have been mild, though more research is needed on its effect on transmission.

Smart temp control technology could be key for COVID-19 vaccine rollout

Some of the hurdles around vaccine distribution could be addressed with high-tech solutions, particularly where environmental management is concerned.